Our analysis showed that G6PD expression was significantly up-regulated as prostate cancer progressed from treatment-naïve to castrate-resistant (Fig. 2E), suggesting that G6PD may be up-regulated in response to disease progression and/or treatment. This evidence concerns the gene G6PD and Familial prostate cancer.